|Articles|May 15, 2002
Exclusive agreement: CIBA Vision signs deal to license Presby products
Atlanta - CIBA Vision has gained exclusive worldwide marketing rights to Presby Corp.'s scleral expansion implants, incision device, and blades for the treatment of presbyopia and, potentially, glaucoma.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
SubscribeAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA grants RMAT designation to Emmecell's EO2002 for corneal endothelial disease
2
Opus Genetics reaches FDA alignment on phase 3 registrational design for OPGx-LCA5 gene therapy
3
NeuroOp Guru: What a big data study reveals about NAION and stroke risk
4
Port Delivery System Therapies in Retinal Vascular Diseases
5


















